Save 20% on All Global Market Reports With Code ONLINE20 – Gain Insights Into Tariffs, Inflation, and Industry Trends
What Is the Potential Market Growth Rate of the Antibody Discovery Market?
The antibody discovery market size has grown strongly in recent years. It will grow from $8.96 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.
The antibody discovery market size is expected to see strong growth in the next few years. It will grow to $14.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.
Claim your free report sample now:
What Are the Primary Growth Contributors in the Antibody Discovery Market?
The growing need for precision therapeutics is expected to propel the growth of the antibody discovery market going forward. Precision therapeutics, also known as personalized therapeutics, refers to the customization of medical treatment plans and interventions to the individual characteristics of each patient. Antibody discovery is used in precision therapeutics, enabling the development of targeted therapies, such as monoclonal antibodies, designed to interact with disease-related molecules or cells specifically and precisely for more effective and personalized treatment. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022 and out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the growing need for precision therapeutics will drive the growth of the antibody discovery market.
What Are the Major Product/Service Segments in the Antibody Discovery Market?
The antibody discovery market covered in this report is segmented –
1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques
Which Trends Are Positively Affecting the Antibody Discovery Market Expansion?
Major companies operating in the antibody discovery market are developing innovative technologies, such as an AI-based computational antibody drug discovery platform, to improve the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational techniques to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company developing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool combines artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to create comprehensive antibody libraries efficiently. This advanced system accelerates the discovery of potential antibody drugs with unprecedented speed.
Who Are the Prominent Players in theAntibody Discovery Market?
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico
Get the full antibody discovery market report here:
What Are the Opportunities and Challenges for Antibody Discovery Market Across Regions?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment